Rimidi is a digital health company focused on chronic disease management and remote patient monitoring. It helps healthcare providers use patient-generated and clinical data to improve workflows, decisions, engagement, and outcomes.
UpMarket does not offer Rimidi shares. This page covers Rimidi's history before the acquisition.
Status
Acquired
By Health Recovery Solutions, Mar 2026
Last Private Valuation
Not confirmed
Not confirmed by two independent reputable sources
How to Review Rimidi's Funding History on UpMarket
Rimidi was acquired by Health Recovery Solutions in March 2026 and no longer has shares of its own. UpMarket does not offer Rimidi shares. This page covers Rimidi's valuation and funding history before the acquisition.
Step 01
Check the acquisition details
Rimidi was acquired by Health Recovery Solutions in March 2026.
Step 02
Review the valuation history
See how Rimidi's private-market valuation changed across funding rounds before the acquisition.
Step 03
Review funding and revenue data
See reported funding rounds and revenue figures on this page, with their sources.
Step 04
Explore private companies
Accredited investors can review UpMarket's current pre-IPO offerings in companies that have not yet gone public.
Pre-IPO investments are illiquid, speculative, and involve risk of total loss of capital.
${{aum_amount_brokered_en}}B+
UpMarket has brokered over ${{aum_amount_brokered_en}} billion in alternative investments*
*Includes principal invested and appreciation of investments originated via the UpMarket platform based on historical trade volume and valuation estimates through {{aum_as_of_date_en}}. Of the total, approximately ${{aum_amount_managed_en}} million is managed by UpMarket Management, with the remaining originated investments managed by affiliates. Past performance is not predictive of future results.
Valuation Growth Over Time
Post-money valuation by round
Previous roundsMost recent
Date
Round
PPS (split-adj.)
Valuation
Rimidi Revenue and Growth
Annual revenue
Why Investors Are Watching Rimidi
Growth Signal
Rimidi says 2024 customer base rose 400% year over year
Rimidi said its customer base increased 400% in 2024, spanning large health systems, community health clinics, and independent physician practices. The company framed the expansion as support for future growth in clinical monitoring.
Competitive Moat
EHR integrations climbed 275%, led by Epic and NextGen
Rimidi reported a 275% increase in EHR integrations in 2021, with the strongest growth among customers using Epic and NextGen EHRs. That integration depth can make switching harder for providers already embedded in those workflows.
Market Opportunity
Senseonics picked Rimidi for Eversense CGM+RPM rollout
Senseonics said it partnered with Rimidi to build its Eversense Remote Patient Monitoring program for health care providers. The company planned availability to select population-health systems in Q3 2024, then expansion to all Eversense prescribers and users.
Looking for companies that are still private? Browse UpMarket's pre-IPO company directory. Accredited investors only.
UpMarket curates and conducts independent diligence on every investment opportunity before it reaches the platform.
Strategy, fees & legal reviewed in full
We review every offering's strategy, risk management, liquidity, fees, valuation methodology, tax matters, and all third-party providers: legal counsel, auditor, administrator, and custodian.
Disciplined managers only
We offer investments exclusively from disciplined managers that pursue unique strategies across an array of asset classes.
Built around your objectives
Our goal is to empower you to build a portfolio that best meets your individual investment objectives.
No. Rimidi was acquired by Health Recovery Solutions in March 2026 and no longer has shares of its own. UpMarket does not offer Rimidi shares.
Rimidi has no stock price of its own since its acquisition by Health Recovery Solutions. The prices shown on this page are historical private-market prices from before the acquisition.
No. Rimidi was acquired by Health Recovery Solutions and UpMarket does not offer Rimidi shares. Accredited investors interested in companies that have not yet gone public can review UpMarket's current pre-IPO offerings.
Rimidi is no longer an independent company, so its shares are not available to buy. This page is kept for its historical funding and valuation data. UpMarket does not offer Rimidi shares.
In a pre-IPO transaction, accredited investors purchase shares from existing shareholders (such as employees, early investors, or other holders) through secondary market platforms. The company itself does not issue new shares in these transactions. UpMarket facilitates these trades as a FINRA-registered broker-dealer, handling compliance, documentation, and settlement on behalf of both parties.
Rimidi was acquired by Health Recovery Solutions in March 2026. What former shareholders received, cash or shares of the buyer, was set by the terms of the acquisition.
UpMarket does not offer Rimidi shares. The minimum for most pre-IPO offerings on UpMarket is $50,000.
Rimidi's last valuation was set by its acquisition by Health Recovery Solutions. The figures on this page show its valuation history before the acquisition.
Rimidi is a digital health company focused on chronic disease management and remote patient monitoring. It was acquired by Health Recovery Solutions in Mar 2026. UpMarket does not offer its shares.